PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $7,000 | -30.0% | 17,075 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $10,000 | +11.1% | 17,075 | 0.0% | 0.00% | – |
Q2 2015 | $9,000 | -35.7% | 17,075 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $14,000 | +27.3% | 17,075 | +21.3% | 0.00% | 0.0% |
Q4 2014 | $11,000 | -50.0% | 14,075 | -34.8% | 0.00% | -50.0% |
Q3 2014 | $22,000 | +15.8% | 21,575 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $19,000 | – | 21,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $8,500 | 0.00% |
LEE DANNER & BASS INC | 50,000 | $4 | 0.00% |
LBMC INVESTMENT ADVISORS, LLC | 22,000 | $1,716 | 0.00% |
Atlas Wealth LLC | 26,620 | $2,249 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,690 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |